26 April 2018

ADC Biotechnology has successfully secured a £1.14m investment from Downing LLP to finance innovative bioconjugation and their US expansion plans

READ PRESS RELEASE

4 February 2018

ADC BIO announces the development of a revolutionary, ‘downstream bio-conjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing.

READ PRESS RELEASE

5 December 2017

ADC BIO has signed a partnership agreement with multi-disciplined engineering specialists, WHP.

READ PRESS RELEASE

14 November 2017

Experts at ADC Bio warn of impending problems in the ADC pipeline with millions wasted in development costs.

READ PRESS RELEASE

25 September 2017

ADC BIO has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK.

READ PRESS RELEASE